Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Number of holders
-
30
-
Total principal
-
305M
-
Principal change
-
+272M
-
Total reported value, excl. options
-
$258M
-
Value change
-
+$233M
-
Number of buys
-
29
-
Price
-
$0.75
Significant Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q3 2015
29 filings reported holding 00767EAB8 - AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q3 2015.
AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 has 30 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $305M of principal
.
Largest 10 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($42.5M of principal), WOLVERINE ASSET MANAGEMENT LLC ($32.9M of principal), AMERIPRISE FINANCIAL INC ($31.9M of principal), Allianz Asset Management AG ($28.7M of principal), BAKER BROS. ADVISORS LP ($26.5M of principal), CITADEL ADVISORS LLC ($20M of principal), ZAZOVE ASSOCIATES LLC ($16.4M of principal), UBS OCONNOR LLC ($15M of principal), PUTNAM INVESTMENTS LLC ($13M of principal), and CITIGROUP INC ($10.6M of principal).
This table shows the top 30 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.